共享还是不共享数据:评估多囊卵巢综合征一线促排卵治疗的试验有多可靠?
该研究是一项元流行病学研究,纳入45项随机对照试验(8697名女性),比较共享与未共享个体参与者数据(IPD)的试验在偏倚风险、注册充分性、统计方法可重复性等方面的质量差异。结果显示,共享IPD的试验低偏倚风险比例更高(76% vs 25%),统计不一致率更低,提示IPD共享与否可作为试验质量的指标。
要点
- 共享IPD的RCT低偏倚风险比例更高(76% vs 25%)。
- 未共享IPD的RCT统计方法问题更多(68% vs 41%)。
- IPD共享与否可作为RCT质量和方法学严谨性的指标。
核心结论
- 共享IPD的RCT在偏倚风险、注册充分性和统计可重复性方面优于未共享IPD的RCT。
- IPD共享的可用性和意愿可能是评估RCT质量和方法学严谨性的良好指标。
研究设计与样本
- 元流行病学研究,纳入45项RCT(8697名女性),其中17项共享IPD,28项未共享IPD。
主要发现
- 共享组低偏倚风险为13/17(76%),未共享组为7/28(25%)。
- 2005年7月1日后招募的试验中,共享组充分注册为3/9(33%),未共享组为0/16(0%)。
- 共享组统计方法问题为7/17(41%),未共享组为19/28(68%)。
- 基线变量不一致率中位数:共享组0%(0-92%),未共享组54%(0-100%)。
- 单变量统计结果不一致率中位数:共享组0%(0-63%),未共享组44%(0-100%)。
关键数值与推荐
- 偏倚风险评估采用RoB 2.0工具。
- 证据质量评估采用GRADE方法。
- 评估注册充分性、统计方法描述和可重复性、基线特征相似性等。
临床怎么用
- 在系统评价和荟萃分析中考虑纳入RCT时,可参考IPD共享情况作为质量指标。
- IPD荟萃分析比聚合数据荟萃分析能提供更准确的风险估计和更透明的获益风险评估。
局限性
- 仅纳入英文全文发表的试验,可能存在选择偏倚。
- 部分分析仅适用于部分试验(如基线变量可重复性分析仅6项共享组和13项未共享组适用)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In our recent individual participant data (IPD) meta-analysis evaluating the effectiveness of first-line ovulation induction for polycystic ovary syndrome (PCOS), IPD were only available from 20 studies of 53 randomized controlled trials (RCTs). We noticed that the summary effect sizes of meta-analyses of RCTs without IPD sharing were different from those of RCTs with IPD sharing. Granting access to IPD for secondary analysis has implications for promoting fair and transparent conduct of RCTs. It is, however, still common for authors to choose to withhold IPD, limiting the impact of and confidence in the results of RCTs and systematic reviews based on aggregate data. OBJECTIVE AND RATIONALE: We performed a meta-epidemiologic study to elucidate if RCTs without IPD sharing have lower quality and more methodological issues than those with IPD sharing in an IPD meta-analysis evaluating first-line ovulation induction for PCOS. SEARCH METHODS: We included RCTs identified for the IPD meta-analysis. We dichotomized RCTs according to whether they provided IPD (shared group) or not (non-shared group) in the IPD meta-analysis. We restricted RCTs to full-text published trials written in English.We assessed and compared RCTs in the shared and non-shared groups on the following criteria: Risk of Bias (RoB 2.0), GRADE approach, adequacy of trial registration; description of statistical methods and reproducibility of univariable statistical analysis; excessive similarity or difference in baseline characteristics that is not compatible with chance; and other miscellaneous methodological issues. OUTCOMES: In total, 45 trials (8697 women) were included in this study. IPD were available from 17 RCTs and 28 trials were categorized as the non-shared IPD group. Pooled risk rates obtained from the shared and non-shared groups were different. Overall low risk of bias was associated with 13/17 (76%) of shared RCTs versus 7/28 (25%) of non-shared RCTs. For RCTs that started recruitment after 1 July 2005, adequate trial registration was found in 3/9 (33%) of shared IPD RCTs versus 0/16 (0%) in non-shared RCTs. In total, 7/17 (41%) of shared RCTs and 19/28 (68%) of non-shared RCTs had issues with the statistical methods described. The median (range) of inconsistency rate per study, between reported and reproduced analyses for baseline variables, was 0% (0-92%) (6 RCTs applicable) in the shared group and 54% (0-100%) (13 RCTs applicable) in the non-shared group. The median (range) of inconsistency rate of univariable statistical results for the outcome(s) per study was 0% (0-63%) (14 RCTs applicable) in the shared group and 44% (0-100%) (24 RCTs applicable) in the non-shared group. The distributions of simulation-generated P-values from comparisons of baseline continuous variables between intervention and control arms suggested that RCTs in the shared group are likely to be consistent with properly conducted randomization (P = 0.163), whereas this was not the case for the RCTs in the non-shared group (P = 4.535 × 10-8). WIDER IMPLICATIONS: IPD meta-analysis on evaluating first-line ovulation induction for PCOS preserves validity and generates more accurate estimates of risk than meta-analyses using aggregate data, which enables more transparent assessments of benefits and risks. The availability of IPD and the willingness to share these data may be a good indicator of quality, methodological soundness and integrity of RCTs when they are being considered for inclusion in systematic reviews and meta-analyses.
引用
- Bordewijk EM, Wang R, van Wely M, et al. To share or not to share data: how valid are trials evaluating first-line ovulation induction for polycystic ovary syndrome? Hum Reprod Update. 2020. PMID: 32935841. doi:10.1093/humupd/dmaa031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。